Discover 3,564 paid clinical trials in Long Beach, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,564
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Location: Fountain Valley CA, Whittier CA, Los Angeles CA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06129864
Phase3, Recruiting
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer (NSCLC)
Location: Fountain Valley CA, San Diego CA, Santa Rosa CA,
Sponsor: Genmab
Sex: All
Age: 18+
Code: NCT07288177
Phase2, Recruiting
DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
for
Relapsed Diffuse Large B-cell Lymphoma,
Location: Fountain Valley CA, Santa Fe NM, Omaha NE, Saskatoon,
Sponsor: ImmunoVaccine Technologies, Inc. (IMV Inc.)
Sex: All
Age: 18+
Code: NCT04920617
Phase2, Recruiting
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
for
Metastatic Non-small Cell Lung Cancer
Location: Fountain Valley CA, La Jolla CA, San Diego CA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06417814
Phase3, Recruiting
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
for
Osteoarthritis, Overweight or Obesity
Location: Fountain Valley CA, Santa Ana CA, Spring Valley CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07353931
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer
for
Advanced Breast Cancer
Location: Fountain Valley CA, Los Angeles CA, Newport Beach CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06380751
Phase3, Recruiting
A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer
for
Platinum-resistant Ovarian Cancer
Location: El Segundo CA, Newport Beach CA
Sponsor: ImmunityBio, Inc.
Sex: Female
Age: 18 - 70+
Code: NCT06710288
Phase2, Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease